FindTrial
Sign In

Establishment and validation of a nomogram for predicting intravenous immunoglobulin resistance and coronary artery lesions involvement in Kawasaki disease

Establishment and validation of a nomogram for predicting intravenous immunoglobulin resistance and coronary artery lesions involvement in Kawasaki disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098653
Enrollment
Unknown
Registered
2025-03-12
Start date
2024-07-20
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki disease

Interventions

Observation group:None

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for Kawasaki disease; 2. Complete laboratory and clinical data;

Exclusion criteria

Exclusion criteria: 1. Patients receiving glucocorticoids or other immunosuppressants during or before the first dose of IVIG therapy; 2. Patients who have not received IVIG treatment in Qilu Hospital of Shandong University; 3. Patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Whether IVIG resistance occurs;Whether or not there is coronary artery dilation;—

Countries

China

Contacts

Public ContactCuifen Zhao

Qilu Hospital of Shandong University

zhaocuifen@sdu.edu.cn+86 531 82165952

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026